Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.57
HAE's Cash-to-Debt is ranked lower than
67% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. HAE: 0.57 )
Ranked among companies with meaningful Cash-to-Debt only.
HAE' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.72 Max: 60.69
Current: 0.57
0.01
60.69
Equity-to-Asset 0.62
HAE's Equity-to-Asset is ranked higher than
54% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. HAE: 0.62 )
Ranked among companies with meaningful Equity-to-Asset only.
HAE' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52  Med: 0.69 Max: 0.84
Current: 0.62
0.52
0.84
Debt-to-Equity 0.39
HAE's Debt-to-Equity is ranked lower than
56% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.35 vs. HAE: 0.39 )
Ranked among companies with meaningful Debt-to-Equity only.
HAE' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01  Med: 0.21 Max: 0.62
Current: 0.39
0.01
0.62
Debt-to-EBITDA 3.22
HAE's Debt-to-EBITDA is ranked lower than
66% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. HAE: 3.22 )
Ranked among companies with meaningful Debt-to-EBITDA only.
HAE' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.03  Med: 1.77 Max: 8.88
Current: 3.22
0.03
8.88
Interest Coverage 0.91
HAE's Interest Coverage is ranked lower than
96% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 44.21 vs. HAE: 0.91 )
Ranked among companies with meaningful Interest Coverage only.
HAE' s Interest Coverage Range Over the Past 10 Years
Min: 0.91  Med: 112.24 Max: 18424.67
Current: 0.91
0.91
18424.67
Piotroski F-Score: 7
Altman Z-Score: 4.40
Beneish M-Score: -3.08
WACC vs ROIC
6.98%
0.36%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 0.58
HAE's Operating Margin % is ranked lower than
59% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.72 vs. HAE: 0.58 )
Ranked among companies with meaningful Operating Margin % only.
HAE' s Operating Margin % Range Over the Past 10 Years
Min: -4.83  Med: 9.26 Max: 16.34
Current: 0.58
-4.83
16.34
Net Margin % 0.48
HAE's Net Margin % is ranked lower than
60% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. HAE: 0.48 )
Ranked among companies with meaningful Net Margin % only.
HAE' s Net Margin % Range Over the Past 10 Years
Min: -6.12  Med: 6.7 Max: 11.82
Current: 0.48
-6.12
11.82
ROE % 0.56
HAE's ROE % is ranked lower than
60% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.68 vs. HAE: 0.56 )
Ranked among companies with meaningful ROE % only.
HAE' s ROE % Range Over the Past 10 Years
Min: -7.18  Med: 7.3 Max: 12.5
Current: 0.56
-7.18
12.5
ROA % 0.33
HAE's ROA % is ranked lower than
59% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.36 vs. HAE: 0.33 )
Ranked among companies with meaningful ROA % only.
HAE' s ROA % Range Over the Past 10 Years
Min: -3.96  Med: 5.47 Max: 10.03
Current: 0.33
-3.96
10.03
ROC (Joel Greenblatt) % 0.93
HAE's ROC (Joel Greenblatt) % is ranked lower than
61% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.63 vs. HAE: 0.93 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HAE' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -7.84  Med: 20.75 Max: 38.15
Current: 0.93
-7.84
38.15
3-Year Revenue Growth Rate -1.40
HAE's 3-Year Revenue Growth Rate is ranked lower than
69% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.90 vs. HAE: -1.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HAE' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -1.4  Med: 7.85 Max: 15
Current: -1.4
-1.4
15
3-Year EBITDA Growth Rate -17.70
HAE's 3-Year EBITDA Growth Rate is ranked lower than
81% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. HAE: -17.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HAE' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 4.75 Max: 105.5
Current: -17.7
0
105.5
GuruFocus has detected 7 Warning Signs with Haemonetics Corp HAE.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HAE's 30-Y Financials

Financials (Next Earnings Date: 2017-11-07)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

HAE Guru Trades in Q3 2016

Steven Cohen 685,800 sh (New)
Jim Simons 883,600 sh (+13.68%)
Ken Fisher 267,712 sh (+3.98%)
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
» More
Q4 2016

HAE Guru Trades in Q4 2016

Paul Tudor Jones 12,246 sh (New)
Jim Simons 895,200 sh (+1.31%)
Ken Fisher 267,667 sh (-0.02%)
Steven Cohen 82,058 sh (-88.03%)
» More
Q1 2017

HAE Guru Trades in Q1 2017

Columbia Wanger 586,290 sh (New)
Joel Greenblatt 15,808 sh (New)
Paul Tudor Jones 27,983 sh (+128.51%)
Steven Cohen Sold Out
Jim Simons 818,600 sh (-8.56%)
Ken Fisher 241,967 sh (-9.60%)
» More
Q2 2017

HAE Guru Trades in Q2 2017

Joel Greenblatt 37,473 sh (+137.05%)
Columbia Wanger 777,492 sh (+32.61%)
Jim Simons 919,800 sh (+12.36%)
Paul Tudor Jones 28,126 sh (+0.51%)
Ken Fisher 241,547 sh (-0.17%)
» More
» Details

Insider Trades

Latest Guru Trades with HAE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Fisher 2017-06-30 Reduce -0.17%$38.93 - $43.2 $ 45.1110%241,547
Joel Greenblatt 2017-06-30 Add 137.05%0.01%$38.93 - $43.2 $ 45.1110%37,473
Ken Fisher 2017-03-31 Reduce -9.60%$36.9 - $41.34 $ 45.1116%241,967
Joel Greenblatt 2017-03-31 New Buy0.01%$36.9 - $41.34 $ 45.1116%15,808
Ken Fisher 2016-12-31 Reduce -0.02%$33.04 - $41.04 $ 45.1120%267,667
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NYSE:HYH, XTER:GXI, NAS:MMSI, ASX:ANN, NAS:NVCR, SZSE:002414, FRA:PHH2, NAS:NXTM, TSE:7732, OSTO:LIFCO B, SZSE:300061, NAS:OSUR, TSE:7747, NAS:ATRI, NAS:PODD, NAS:IRTC, MIL:AMP, NYSE:GKOS, TSE:3593, SZSE:300171 » details
Traded in other countries:HAZ.Germany,
Headquarter Location:USA
Haemonetics Corp is a health care company. It provides products enabling the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.

Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in four categories: Plasma, Hemostasis Management, Blood Center and Cell Processing. The Plasma business includes plasma collection devices and disposables. Hemostasis Management includes devices and methodologies for measuring coagulation characteristics of blood, Blood Center includes blood collection and processing devices and disposables for red cells and Cell Processing include surgical blood salvage systems, specialized blood cell processing systems, disposables and blood transfusion management software.

Ratios

vs
industry
vs
history
PE Ratio 644.41
HAE's PE Ratio is ranked lower than
100% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.08 vs. HAE: 644.41 )
Ranked among companies with meaningful PE Ratio only.
HAE' s PE Ratio Range Over the Past 10 Years
Min: 18.81  Med: 28.25 Max: 661.57
Current: 644.41
18.81
661.57
Forward PE Ratio 27.62
HAE's Forward PE Ratio is ranked lower than
60% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.51 vs. HAE: 27.62 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 644.41
HAE's PE Ratio without NRI is ranked lower than
100% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. HAE: 644.41 )
Ranked among companies with meaningful PE Ratio without NRI only.
HAE' s PE Ratio without NRI Range Over the Past 10 Years
Min: 18.63  Med: 28.09 Max: 661.57
Current: 644.41
18.63
661.57
Price-to-Owner-Earnings 263.79
HAE's Price-to-Owner-Earnings is ranked lower than
99% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.51 vs. HAE: 263.79 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HAE' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 16.43  Med: 34.9 Max: 270.82
Current: 263.79
16.43
270.82
PB Ratio 3.07
HAE's PB Ratio is ranked higher than
53% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.25 vs. HAE: 3.07 )
Ranked among companies with meaningful PB Ratio only.
HAE' s PB Ratio Range Over the Past 10 Years
Min: 1.84  Med: 2.53 Max: 3.4
Current: 3.07
1.84
3.4
PS Ratio 2.67
HAE's PS Ratio is ranked higher than
56% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.36 vs. HAE: 2.67 )
Ranked among companies with meaningful PS Ratio only.
HAE' s PS Ratio Range Over the Past 10 Years
Min: 1.47  Med: 2.34 Max: 3.41
Current: 2.67
1.47
3.41
Price-to-Free-Cash-Flow 23.49
HAE's Price-to-Free-Cash-Flow is ranked higher than
64% of the 72 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.99 vs. HAE: 23.49 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HAE' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 15.8  Med: 33.85 Max: 497.33
Current: 23.49
15.8
497.33
Price-to-Operating-Cash-Flow 14.05
HAE's Price-to-Operating-Cash-Flow is ranked higher than
70% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.95 vs. HAE: 14.05 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HAE' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.91  Med: 14.03 Max: 25.67
Current: 14.05
9.91
25.67
EV-to-EBIT 490.00
HAE's EV-to-EBIT is ranked lower than
98% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.17 vs. HAE: 490.00 )
Ranked among companies with meaningful EV-to-EBIT only.
HAE' s EV-to-EBIT Range Over the Past 10 Years
Min: -124.9  Med: 16.75 Max: 504.2
Current: 490
-124.9
504.2
EV-to-EBITDA 26.64
HAE's EV-to-EBITDA is ranked lower than
75% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.83 vs. HAE: 26.64 )
Ranked among companies with meaningful EV-to-EBITDA only.
HAE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.2  Med: 13.3 Max: 61.4
Current: 26.64
8.2
61.4
EV-to-Revenue 2.84
HAE's EV-to-Revenue is ranked higher than
58% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. HAE: 2.84 )
Ranked among companies with meaningful EV-to-Revenue only.
HAE' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.8  Med: 2.3 Max: 3.2
Current: 2.84
1.8
3.2
Shiller PE Ratio 63.03
HAE's Shiller PE Ratio is ranked lower than
59% of the 51 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.91 vs. HAE: 63.03 )
Ranked among companies with meaningful Shiller PE Ratio only.
HAE' s Shiller PE Ratio Range Over the Past 10 Years
Min: 25.71  Med: 35.64 Max: 64.32
Current: 63.03
25.71
64.32
Current Ratio 2.57
HAE's Current Ratio is ranked higher than
50% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. HAE: 2.57 )
Ranked among companies with meaningful Current Ratio only.
HAE' s Current Ratio Range Over the Past 10 Years
Min: 1.85  Med: 3.03 Max: 4.92
Current: 2.57
1.85
4.92
Quick Ratio 1.72
HAE's Quick Ratio is ranked lower than
54% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. HAE: 1.72 )
Ranked among companies with meaningful Quick Ratio only.
HAE' s Quick Ratio Range Over the Past 10 Years
Min: 1.07  Med: 2.1 Max: 4.22
Current: 1.72
1.07
4.22
Days Inventory 132.67
HAE's Days Inventory is ranked lower than
51% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.23 vs. HAE: 132.67 )
Ranked among companies with meaningful Days Inventory only.
HAE' s Days Inventory Range Over the Past 10 Years
Min: 89.4  Med: 110.49 Max: 156.73
Current: 132.67
89.4
156.73
Days Sales Outstanding 62.34
HAE's Days Sales Outstanding is ranked lower than
52% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.37 vs. HAE: 62.34 )
Ranked among companies with meaningful Days Sales Outstanding only.
HAE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 58.47  Med: 67.5 Max: 84.99
Current: 62.34
58.47
84.99
Days Payable 28.30
HAE's Days Payable is ranked lower than
80% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.31 vs. HAE: 28.30 )
Ranked among companies with meaningful Days Payable only.
HAE' s Days Payable Range Over the Past 10 Years
Min: 26.02  Med: 31.53 Max: 41.58
Current: 28.3
26.02
41.58

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 47.99
HAE's Price-to-Net-Current-Asset-Value is ranked lower than
94% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.73 vs. HAE: 47.99 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
HAE' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.83  Med: 6.26 Max: 193.19
Current: 47.99
3.83
193.19
Price-to-Tangible-Book 6.10
HAE's Price-to-Tangible-Book is ranked lower than
60% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.82 vs. HAE: 6.10 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
HAE' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.69  Med: 3.46 Max: 13.8
Current: 6.1
1.69
13.8
Price-to-Intrinsic-Value-Projected-FCF 2.28
HAE's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
52% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.18 vs. HAE: 2.28 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HAE' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.11  Med: 1.62 Max: 2.56
Current: 2.28
1.11
2.56
Price-to-Median-PS-Value 1.13
HAE's Price-to-Median-PS-Value is ranked higher than
52% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. HAE: 1.13 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HAE' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.54  Med: 0.98 Max: 1.55
Current: 1.13
0.54
1.55
Price-to-Graham-Number 13.23
HAE's Price-to-Graham-Number is ranked lower than
99% of the 91 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. HAE: 13.23 )
Ranked among companies with meaningful Price-to-Graham-Number only.
HAE' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.06  Med: 1.96 Max: 13.42
Current: 13.23
1.06
13.42
Earnings Yield (Greenblatt) % 0.20
HAE's Earnings Yield (Greenblatt) % is ranked lower than
60% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.49 vs. HAE: 0.20 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HAE' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -3.2  Med: 5.05 Max: 8.5
Current: 0.2
-3.2
8.5
Forward Rate of Return (Yacktman) % -12.64
HAE's Forward Rate of Return (Yacktman) % is ranked lower than
91% of the 97 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.48 vs. HAE: -12.64 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HAE' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -16  Med: 8.45 Max: 17.5
Current: -12.64
-16
17.5

More Statistics

Revenue (TTM) (Mil) $887.11
EPS (TTM) $ 0.07
Beta0.95
Short Percentage of Float4.26%
52-Week Range $32.76 - 46.85
Shares Outstanding (Mil)52.61

Analyst Estimate

Mar18 Mar19
Revenue (Mil $) 889 920
EPS ($) 1.65 1.85
EPS without NRI ($) 1.65 1.85
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.00%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}